Return to Home [X]

Exciting News: Introducing the New Essential Evidence Plus!

We are thrilled to announce that a brand-new version of Essential Evidence Plus is on its way! Mark your calendars for the launch date, September 11th, as we are introducing a modern, mobile-first application that will revolutionize your experience. With this update, accessing our valuable content will be easier and more convenient than ever before.

What to Expect from the New Essential Evidence Plus:

  1. Modern Mobile-First Experience: Our new application has been meticulously designed with a mobile-first approach. No matter what device you're using, whether it's a smartphone, tablet, or desktop, you'll enjoy a seamless and intuitive user experience.
  2. Enhanced Accessibility: We understand the importance of accessing content from anywhere, at any time. The new Essential Evidence Plus will provide you with the flexibility to explore our extensive collection of evidence-based resources on the go, making it easier to stay up to date with the latest medical knowledge and interactive tools.
  3. Improved User Interface: We have revamped our user interface to ensure effortless navigation and a visually appealing experience. Finding the information, you need will be quicker and more intuitive, saving you valuable time and effort.

Essential Evidence Plus will be available to users during this transition. However, please note that ability to create new trial and individual subscriptions will not be available from September 8th to September 11th 7:00 AM EST. During this period, we will be working diligently to transfer our existing system to the upgraded platform, ensuring a seamless transition for all users.

We apologize for any inconvenience caused by this temporary interruption. Rest assured, our team is committed to bringing you a superior user experience, and we appreciate your patience and understanding during this time.

Stay Tuned for the New Essential Evidence Plus!

We are counting down the days until September 11th when the new Essential Evidence Plus will be available for you to explore. Get ready to unlock a wealth of evidence-based resources that empower you in your medical decision-making process.

Thank you for your continued support, and we look forward to delivering an exceptional experience with the all-new Essential Evidence Plus!

Essential Evidence Plus
Learn about the new Essential Evidence Plus X

Browse Databases and Tools

Showing 1-17 of 17 for: Decision Support Tools > Gastroenterology: Hepatic Remove Constraint

Sort by Show per page
  • Abnormal liver function work-up LOE 5
    Decision Support Tools, 1-Sep-2003
  • Bleeding risk after hepatic resection LOE 1a
    Decision Support Tools, 1-Jul-2009
  • Cirrhosis probability in patients with hep C (HALT-C) LOE 1a
    Decision Support Tools, 2-Jul-2014
  • Cirrhosis: probability of varices LOE 1a
    Decision Support Tools, 1-Sep-2003
  • End stage liver disease prognosis (MELD) LOE 1a
    Decision Support Tools, 1-Jun-2003
  • Fibrosis (severe) in NASH LOE 2b
    Decision Support Tools, 1-Sep-2003
  • Fibrosis probability (FIB4 index) LOE 1a
    Decision Support Tools, 1-Jun-2010
  • Hepatic resection 90 day mortality LOE 1a
    Decision Support Tools, 2-Jul-2013
  • Hepatic resection readmission prediction (RRS) LOE 1a
    Decision Support Tools, 2-Jul-2015
  • Hepatitis C: probability of cirrhosis LOE 1a
    Decision Support Tools, 1-Jun-2003
  • Hepatitis C: probability of fibrosis LOE 1a
    Decision Support Tools, 1-Sep-2003
  • Hepatitis C: prognosis LOE 1a
    Decision Support Tools, 1-Dec-2002
  • Hepatitis C: prognosis of advanced hepatic fibrosis LOE 1a
    Decision Support Tools, 1-Nov-2016
  • NASH in obese patients (HAIR score) LOE 2b
    Decision Support Tools, 1-Sep-2003
  • Predicting alcoholic cause of steatohepatitis (ALD/NAFLD Index or ANI) LOE 1a
    Decision Support Tools, 19-Jul-2021
  • Probability of fibrosis in patients with non-alcoholic fatty liver (NAFLD Fibrosis Score) LOE 1A
    Decision Support Tools, 1-Jun-2018
  • Probability of severe fibrosis in hepatitis C LOE 1a
    Decision Support Tools, 1-Jul-2009
[x]

Login or Subscribe

Login

Not Yet a Subscriber?

Doctor with handheld

We offer subscriptions for individuals and institutions

To find out about all the benefits of a year-long subscription to Essential Evidence Plus, click the button below!

Learn More